[Double blind comparative clinical evaluation of a new anxiolytic agent, Zami-905: propazepam].
作者信息
Carbonell Masía D C, Calvé Pérez A
出版信息
Actas Luso Esp Neurol Psiquiatr Cienc Afines. 1976 Nov-Dec;4(6):377-86.
PMID:19933
Abstract
摘要
相似文献
1
[Double blind comparative clinical evaluation of a new anxiolytic agent, Zami-905: propazepam].
Actas Luso Esp Neurol Psiquiatr Cienc Afines. 1976 Nov-Dec;4(6):377-86.
2
[Open clinical trial with pinazepam].
Clin Ter. 1976 Aug 15;78(3):219-26.
3
[Alprazolam vs. oxazepam in the treatment of anxious-neurotic patients].
Schweiz Rundsch Med Prax. 1985 Oct 29;74(44):1199-203.
4
[Double-blind test with a new benzodiazepine derivative (camazepam)].
Med Monatsschr. 1976 Sep;30(9):413-5.
5
[Clinical experiences with the new-generation anxiolytic agent cloxazolam--a double-blind study].
Schweiz Rundsch Med Prax. 1985 Jul 2;74(27):728-34.
6
Multicenter trials and complementary studies of cloxazolam, a new anxiolytic drug.
Arzneimittelforschung. 1981;31(10):1757-65.
7
[Bromazepam versus placebo. Double-blind crossover study].
Schweiz Rundsch Med Prax. 1984 Jan 31;73(5):143-8.
8
[Double-blind trial treatment of anxiety with b 5833].
Acta Psychiatr Belg. 1974 May;74(3):317-26.
9
[Clinical effectiveness of clorazepate dipotassium (Tranxilium 20), used in a single daily dose, in neurotic disorders].
Psychiatr Pol. 1983;17(1):25-9.
10
Therapy of neurotic and pseudoneurotic symptoms with tofisopam.
Agressologie. 1981 Nov;22(D):21-2.
Zotero 插件